CEO Post: Pfizer Vet Leads 1 New Phase 3 Biotech Firm
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
An exclusive look at the new ceo set to steer Parfums de Marly and Initio Parfums Privés. Learn about the future direction for these luxury fragrance brands.